Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Oct. 27, 2012	Oct. 29, 2011
Cash flows from operating activities:
Net loss	$ (37,028)	$ (4,066)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Amortization of deferred financing costs	666	732
Depreciation and amortization	10,349	5,839
(Recovery) provision for losses on accounts receivable	(51)	136
Share-based compensation expense	4,268	20
Change in operating assets and liabilities net of effect of acquisition:
Accounts receivable	(22,192)	(15,241)
Inventories	(42,920)	(30,978)
Prepaid expenses and other assets	2,320	(2,411)
Accounts payable	25,173	33,836
Accounts payable-affiliates	1,957	3,763
Accrued expenses and other liabilities and other long-term liabilities	7,358	11,676
Net cash (used in) provided by operating activities	(50,100)	3,306
Cash flows from investing activities:
Additions to property and equipment	(5,575)	(2,658)
Payment to acquire Parlux, net of Parlux cash on hand of $17,114	(44,949)	0
Net cash used in investing activities	(50,524)	(2,658)
Cash flows from financing activities:
Net borrowings under bank line of credit	71,191	410
Payments on affiliated notes payable	0	(373)
Borrowings under affiliated notes payable to fund Parlux acquisition	30,000	0
Principal payments under capital lease obligations	(809)	(688)
Proceeds from exercise of stock options	83	10
Net cash provided by (used in) financing activities	100,465	(641)
Net (decrease) increase in cash and cash equivalents	(159)	7
Cash and cash equivalents at beginning of period	1,682	1,236
Supplemental Information:
Cash paid during the period for Interest	1,462	1,412
Cash paid during the period for Income taxes	327	853
Fair value of equity consideration given to acquire Parlux	$ 89,563	$ 0